It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BACKGROUND: We aimed to investigate the effects of brachytherapy, drug-eluting stent (DES)
and bare metal stent (BMS) applications in the treatment of coronary artery disease, on five-
-year clinical outcomes and mortality.
METHODS: Two hundred and seventeen patients who were treated in our clinics between
January 2000 and December 2003 with brachytherapy, DES, or BMS for both de novo and in-
-stent restenosis lesions were included in this cohort study. Of these 217 patients, 69 received
brachytherapy, 80 were given BMS and 68 were given DES. The clinical outcomes of the
patients during hospitalization and over a long-term follow-up were evaluated. Cardiovascular
events, revascularizations and mortality rates were compared among the three groups over
a five-year follow-up.
RESULTS: The mean age was 60.1 ± 9.5 years in the brachytherapy group, 55.7 ± 9.2 years in
the BMS group, and 58.9 ± 9.8 years in the DES group (p = 0.44). All-cause mortality rates
were 20 (29%) brachytherapy patients, 22 (27.5%) BMS patients, and four (5.9%) DES
patients (p = 0.01). Cardiovascular event was the cause of death for 14 (20.3%) brachytherapy
patients, 16 (20%) BMS patients and four (5.9%) DES patients (p = 0.001). All-cause
mortality rates were 20 (29%) brachytherapy patients, 22 (27.5%) BMS patients and four
(5.9%) DES patients. All-cause and cardiovascular mortality rates were significantly lower in the
DES group compared to both the BMS and the brachytherapy groups (p = 0.01 and p = 0.001,
respectively).
CONCLUSIONS: DES application for in-stent restenosis and de novo lesions was superior to
brachytherapy and BMS application with respect to all-cause and cardiovascular mortalities.
(Cardiol J 2011; 18, 6: 654–661)
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer